›Afebrile with stable vitals after analgesia and drainage
›Reliable follow-up and return precautions
08Treatment/t53
Source control and procedural management
›Drainage strategy
›Bedside incision and drainage suitability
›Superficial perianal abscess with clear fluctuance
›No systemic toxicity
›Operative drainage suitability
›Perirectal or deep anorectal abscess suspicion
›Ischiorectal or supralevator involvement
›Recurrent or complex anatomy
›Analgesia and anesthesia
›Local anesthetic infiltration planning
›Procedural sedation planning if needed and safe
Antibiotics
›Antibiotic decision framework
›Antibiotics not routine after uncomplicated drainage
›If no cellulitis and no systemic illness, reserve antibiotics
›If immunocompetent and localized abscess, drainage alone often sufficient
›Antibiotics indicated scenarios
›Surrounding cellulitis
›Systemic signs of infection
›Diabetes mellitus with significant infection
›Immunocompromised host
›Valvular heart disease or prosthetic material per local policy
›Outpatient regimens when indicated
›Amoxicillin clavulanate PO
›875 mg and 125 mg PO every 12 hours
›Duration 5 to 7 days
›Renal dosing adjustment if reduced eGFR
›Ciprofloxacin plus metronidazole PO
›Ciprofloxacin 500 mg PO every 12 hours
›Duration 5 to 7 days
›Tendinopathy risk counseling
›Metronidazole 500 mg PO every 8 hours
›Duration 5 to 7 days
›Avoid alcohol during therapy
›Inpatient regimens for severe infection
›Piperacillin tazobactam IV
›4.5 g IV every 6 to 8 hours per local protocol
›Renal dosing adjustment
›De-escalation after cultures and source control
›MRSA coverage when risk features present
›If prior MRSA, severe purulence with systemic illness, or failed prior therapy, add MRSA active agent per local antibiogram
›Reassess necessity after drainage and cultures
›Avoid duplicative gram positive coverage
Supportive care
›Symptom control
›Pain control
›Acetaminophen dosing per weight and max daily
›NSAID use if no contraindication
›Opioid short course if severe pain and safe
›Bowel regimen
›Stool softener to reduce pain with defecation
›Fiber and hydration plan
›Wound care adjuncts
›Sitz baths for comfort and hygiene
›Dressing and drainage expectations counseling
09Special Populations/sp27
Pregnancy
›Pregnancy considerations
›Diagnostic approach
›Lower threshold for ultrasound and surgical consultation
›CT risk benefit discussion when deep abscess suspected
›Antibiotic selection
›Avoid teratogenic agents based on trimester
›Beta lactam based regimens preferred when appropriate
›Disposition
›Lower threshold for admission with systemic features
Geriatric
›Older adult considerations
›Atypical presentation
›Blunted fever response
›Delirium as infection marker
›Medication safety
›Renal dosing for antibiotics
›NSAID risk assessment
›Disposition
›Lower threshold for admission if frailty or limited supports
Pediatrics
›Pediatric considerations
›Differential expansion
›Perianal streptococcal dermatitis
›Congenital fistula considerations in infants
›Management nuances
›Weight-based analgesia dosing
›Surgical consultation for suspected deep abscess
›Safeguarding
›Consider non-accidental trauma if concerning history or exam
10Background/b25
Epidemiology
›Epidemiologic facts
›Typical source
›Cryptoglandular infection as common mechanism
›Association with fistula in ano development
›Risk enrichment
›Increased risk with Crohn disease
›Increased severity risk with diabetes and immunosuppression
Pathophysiology
›Mechanistic outline
›Gland obstruction
›Anal crypt infection progression
›Spread along anorectal spaces
›Anatomic spaces
›Perianal space
›Intersphincteric space
›Ischiorectal space
›Supralevator space
Therapeutic Considerations
›Treatment rationale
›Source control primacy
›Drainage as definitive initial therapy
›Antibiotics adjunctive in selected patients
›Imaging value
›Mapping deep collections to prevent missed abscess
›Identifying fistula and Crohn patterns in recurrent disease
›Follow-up importance
›Fistula development surveillance after abscess
11Patient Discharge Instructions/pdi22
Copy discharge instructions
›Discharge packet
›Wound care
›Keep area clean and dry between dressing changes
›Warm sitz baths 10 to 15 minutes several times daily as tolerated
›Expect ongoing drainage for several days
›Pain and bowel care
›Acetaminophen and ibuprofen use per label unless contraindicated
›Stool softener and fiber to avoid straining
›Hydration goal with clear urine
›Antibiotics
›If prescribed, complete full course
›If rash, swelling, or trouble breathing, stop and seek urgent care
›Return to ED now
›Fever or shaking chills
›Rapidly worsening pain or swelling
›Spreading redness
›New foul smell or black or gray skin changes
›Difficulty urinating or inability to pass urine
›Dizziness, fainting, or confusion
›Follow-up
›Surgical follow-up in 24 to 72 hours if directed
›Reassessment if persistent drainage beyond expected course
12References/r11
Guidelines and core sources
›Key guideline set
›American Society of Colon and Rectal Surgeons clinical practice guideline for anorectal abscess and fistula in ano
›Antibiotics reserved for selected patients with cellulitis or systemic illness
›Imaging and fistula evaluation in recurrent or complex disease
›Canadian Association of General Surgeons perianal abscess clinical practice guidance
›CT with IV or rectal contrast for suspected deep anorectal abscess not palpable on exam
›MRI utility for fistula and Crohn evaluation
Coding references
›ICD-10 sources
›ICD-10 K61.1 rectal abscess includes perirectal abscess
›Abscess of anal and rectal regions grouping K61
›Exclusion distinctions for ischiorectal and intrasphincteric codes
Evidence & Review
Reviewed by SymptomDx Medical Team·Last reviewed
SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.